Literature DB >> 22366263

Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential.

Federica Barbieri1, Roberto Wurth, Alessandra Ratto, Chiara Campanella, Guendalina Vito, Stefano Thellung, Antonio Daga, Michele Cilli, Angelo Ferrari, Tullio Florio.   

Abstract

Current carcinogenesis theory states that only a small subset of tumor cells, the cancer stem cells or tumor initiating cells (TICs), are responsible for tumor formation and progression. Human breast cancer-initiating cells have been identified as CD44-expressing cells, which retain tumorigenic activity and display stem cell-like properties. Spontaneous feline mammary carcinoma (FMC) is an aggressive cancer, which shows biological similarities to the human tumor counterpart. We report the isolation and phenotypic characterization of FMC-derived stem/progenitor cells, showing in vitro self-renewal, long-lasting proliferation and in vivo tumorigenicity. Twenty-one FMC samples were collected, histologically classified and characterized for the expression of Ki67, EGFR, ER-α and CD44, by immunohistochemistry. By culture in stem cell permissive conditions, we isolated, from 13 FMCs, a CD44-positive subpopulation able to survive and proliferate in vitro as mammospheres of different sizes and morphologies. When injected in NOD/SCID mice, FMC stem-like cells initiate tumors, generating cell heterogeneity and recapitulating the original histotype. In serum-containing medium, spheroid cells showed differentiation properties as shown by morphological changes, the loss of CD44 expression and tumorigenic potential. These data show that stem-defined culture of FMC enriches for TICs and validate the use of these cells as a suitable model for comparative oncology studies of mammary biology and testing therapeutic strategies aimed at eradicating TICs. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366263     DOI: 10.1016/j.yexcr.2012.02.008

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

Review 1.  Mammary stem cell research in veterinary science: an update.

Authors:  Bizunesh M Borena; Leen Bussche; Christian Burvenich; Luc Duchateau; Gerlinde R Van de Walle
Journal:  Stem Cells Dev       Date:  2013-03-05       Impact factor: 3.272

2.  Targeted Toxin Gene Therapy Of Breast Cancer Stem Cells Using CXCR1 Promoter And bFGF 5'UTR.

Authors:  Cobra Moradian; Fatemeh Rahbarizadeh
Journal:  Onco Targets Ther       Date:  2019-10-25       Impact factor: 4.147

3.  In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.

Authors:  Federica Barbieri; Stefano Thellung; Alessandra Ratto; Elisa Carra; Valeria Marini; Carmen Fucile; Adriana Bajetto; Alessandra Pattarozzi; Roberto Würth; Monica Gatti; Chiara Campanella; Guendalina Vito; Francesca Mattioli; Aldo Pagano; Antonio Daga; Angelo Ferrari; Tullio Florio
Journal:  BMC Cancer       Date:  2015-04-07       Impact factor: 4.430

Review 4.  Identification and characterization of cancer stem cells in canine mammary tumors.

Authors:  Agata Rybicka; Magdalena Król
Journal:  Acta Vet Scand       Date:  2016-12-19       Impact factor: 1.695

Review 5.  Large Animal Models of Breast Cancer.

Authors:  Pinaki Mondal; Katie L Bailey; Sara B Cartwright; Vimla Band; Mark A Carlson
Journal:  Front Oncol       Date:  2022-02-04       Impact factor: 6.244

6.  Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways.

Authors:  Hugo Murua Escobar; Ingo Nolte; José Luis Granados-Soler; Leila Taher; Julia Beck; Kirsten Bornemann-Kolatzki; Bertram Brenig; Verena Nerschbach; Fernando Ferreira; Johannes Junginger; Marion Hewicker-Trautwein
Journal:  Sci Rep       Date:  2022-10-11       Impact factor: 4.996

7.  Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM/p53 DNA damage pathway.

Authors:  L Y Pang; T M Blacking; R W Else; A Sherman; H M Sang; B A Whitelaw; T R Hupp; D J Argyle
Journal:  Vet J       Date:  2012-12-07       Impact factor: 2.688

8.  n-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1.

Authors:  Tsung-Hua Hsieh; Cheng-Fang Tsai; Chia-Yi Hsu; Po-Lin Kuo; Edward Hsi; Jau-Ling Suen; Chih-Hsing Hung; Jau-Nan Lee; Chee-Yin Chai; Shao-Chun Wang; Eing-Mei Tsai
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

9.  TiHo-0906: a new feline mammary cancer cell line with molecular, morphological, and immunocytological characteristics of epithelial to mesenchymal transition.

Authors:  José Luis Granados-Soler; Johannes Junginger; Marion Hewicker-Trautwein; Kirsten Bornemann-Kolatzki; Julia Beck; Bertram Brenig; Daniela Betz; Jan Torben Schille; Hugo Murua Escobar; Ingo Nolte
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.